« Back to Record
Citation APA

Bines, J., Clark, E., Barton, C. C., Restuccia, E., Procter, M., Sonnenblick, A., Fumagalli, D., Parlier, D., Arahmani, A., Baselga, J., Viale, G., Reaby, L., Frank, E. E., Gelber, R., Piccart-Gebhart, M., Jackisch, C., & Petersen, J. J. (2021). Patient-reported function, health-related quality of life, and symptoms in APHINITY: pertuzumab plus trastuzumab and chemotherapy in HER2-positive early breast cancer. British Journal of Cancer. doi:10.1038/s41416-021-01323-y


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/322383

Bines, J., Clark, E., Barton, C. C., Restuccia, E., Procter, M., Sonnenblick, A., Fumagalli, D., Parlier, D., Arahmani, A., Baselga, J., Viale, G., Reaby, L., Frank, E. E., Gelber, R., Piccart-Gebhart, M., Jackisch, C., & Petersen, J. J. (2021). Patient-reported function, health-related quality of life, and symptoms in APHINITY: pertuzumab plus trastuzumab and chemotherapy in HER2-positive early breast cancer. British Journal of Cancer. doi:10.1038/s41416-021-01323-y